Arrowhead Pharmaceuticals, Inc.
ARWR
Jodie situation report
Arrowhead Pharmaceuticals, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 11 directly disclosed connections are confirming.
- ARWR's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if ARWR's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind ARWR
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
NVSNovartis AGpartnerFeb 5, 2026 ▾
“Over the past several years we have entered into license and collaboration agreements with Takeda, Janssen, Amgen, Horizon, GSK, Sarepta, Visirna and Novartis Pharma AG (“Novartis”).”
SNYSanofipartnerFeb 5, 2026 ▾
“Under our licensing and collaboration agreements with Amgen, Takeda, GSK, Sarepta, Visirna, Sanofi, and Novartis, our partners substantially control clinical development and commercialization for all of the candidates covered under those agreements in their r…”
Depended on by
AKBAAkebia Therapeutics, Inc.partnerFeb 26, 2026 ▾
“A number of complement inhibitors are in development for the treatment of IgAN by companies including Alexion Pharmaceuticals, (ULTOMIRIS, ravulizumab, C5 inhibitor, Phase 3), Apellis (EMPAVELI, pegcetacoplan, C3 inhibitor, Phase 2), and Arrowhead Pharmaceuti…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 9 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ARWR is currently a Leader in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for ARWR; it is not active in the latest market snapshot.